Conference Chair
Sandeep Samant, MD
Chief, Head & Neck Surgery
Northwestern Medicine
Lurie Cancer Center Professional Education Events
2022 Lurie Cancer Center Multidisciplinary Head & Neck SymposiumThe Lurie Cancer Center Multidisciplinary Head & Neck Symposium is a two-day interactive program on the diagnosis, treatment and rehabilitation of head and neck cancer patients. The symposium brings together medical oncologists, radiation oncologists, otolaryngologists, head and neck surgeons, dentists, nurses, and allied health professionals to discuss and debate the latest advances in multidisciplinary therapies, clinical research and supportive care methodology. The agenda features internationally-recognized experts who will engage attendees in dialogue to improve multi-specialty collaboration in the treatment and care of head and neck cancer patients.
2022 Presentation SlidesEvent Details
December 2-3, 2022
December 2, 2022 | 7:45 a.m. - 5:15 p.m.
December 3, 2022 | 8:00 a.m. - 3:15 p.m.
Prentice Women's Hospital
250 E. Superior St., Chicago
3rd Floor, Conference Room L
Registration & Fee Information
Registration fees, CME information and other details
Agenda
Download and print our brochure with agenda
Exhibitor Prospectus
Download and print our Exhibitor Prospectus
Co-Chairs
Jochen Lorch, MD, MSc
Professor, Hematology & Oncology
Bharat Mitttal, MD
Chair, Radiation Oncology
Scientific Planning Committee
Laila Gharzai, MD
Radiation Oncology
Urjeet Patel, MD
Head & Neck Surgery
Katelyn Stepan, MD
Head & Neck Surgery
Faculty
Borislav Alexiev, MD
Lurie Cancer Center
Fred Baik, MD
Stanford Cancer Center
Barbara Burtness, MD
Yale Medicine
Sunandana Chandra, MD, MS
Lurie Cancer Center
Bhisham Chera, MD
Medical University of South Carolina
Jennifer Choi, MD
Lurie Cancer Center
John Cramer, MD
Karmanos Cancer Center
John De Almeida, MD, MSc
Univeristy of Toronto
Uma Duvvuri, MD, PhD
Pittsburgh School of Medicine
Laila Gharzai, MD
Lurie Cancer Center
Alan Ho, MD, PhD
Memorial Sloan Kettering Cancer Center
Chris Holsinger, MD, FACS
Stanford University
Mark Hutten, DDS
Lurie Cancer Center
Lurie Cancer Center
Fred Baik, MD
Stanford Cancer Center
Barbara Burtness, MD
Yale Medicine
Sunandana Chandra, MD, MS
Lurie Cancer Center
Bhisham Chera, MD
Medical University of South Carolina
Jennifer Choi, MD
Lurie Cancer Center
John Cramer, MD
Karmanos Cancer Center
John De Almeida, MD, MSc
Univeristy of Toronto
Uma Duvvuri, MD, PhD
Pittsburgh School of Medicine
Laila Gharzai, MD
Lurie Cancer Center
Alan Ho, MD, PhD
Memorial Sloan Kettering Cancer Center
Chris Holsinger, MD, FACS
Stanford University
Mark Hutten, DDS
Lurie Cancer Center
Stephen Lai, MD, PhD
Memorial Sloan Kettering Cancer Center
Whitney Liddy, MD
Lurie Cancer Center
Jochen Lorch, MD
Lurie Cancer Center
Dan Ma, MD
Mayo Clinic Cancer Center
Michelle Mierzwa, MD
University of Michigan
Rogel Cancer Center
Bharat Mittal, MD
Lurie Cancer Center
Eric Nesbit, MD
Lurie Cancer Center
Jason Newman, MD
Medical University of South Carolina
Daniel Olson, MD
University of Chicago Medicine
Alexis B. Olsson, DDS
Lurie Cancer Center
Ioannis Papagiannis, MD
Lurie Cancer Center
Urjeet Patel, MD
Lurie Cancer Center
Sidharth Puram, MD, PhD
Siteman Cancer Center
Nabil Saba, MD
Winship Cancer Institute
Sandeep Samant, MD
Lurie Cancer Center
Kerstin Stenson, MD
Rush University Medical Center
Katelyn Stepan, MD
Lurie Cancer Center
Cord Sturgeon, MD
Lurie Cancer Center
Tarita Thomas, MD, PhD
Lurie Cancer Center
Wade Thorstad, MD
Siteman Cancer Center
Ravindra Uppaluri, MD, PhD
Dana-Farber Cancer Institute
Jeffrey Wayne, MD
Lurie Cancer Center
Frank Worden, MD
University of Michigan
Rogel Cancer Center
Sue Yom, MD, PhD
University of California San Francisco
Simon Yoo, MD
Lurie Cancer Center
Mark Zafereo, MD
MD Anderson Cancer Center
Lurie Cancer Center
Kerstin Stenson, MD
Rush University Medical Center
Katelyn Stepan, MD
Lurie Cancer Center
Cord Sturgeon, MD
Lurie Cancer Center
Tarita Thomas, MD, PhD
Lurie Cancer Center
Wade Thorstad, MD
Siteman Cancer Center
Ravindra Uppaluri, MD, PhD
Dana-Farber Cancer Institute
Jeffrey Wayne, MD
Lurie Cancer Center
Frank Worden, MD
University of Michigan
Rogel Cancer Center
Sue Yom, MD, PhD
University of California San Francisco
Simon Yoo, MD
Lurie Cancer Center
Mark Zafereo, MD
MD Anderson Cancer Center
Accommodations & Parking
Hotel Accommodations
Chicago is a popular vacation and convention destination. We recommend that you make your reservations at any of the large number of nearby hotels as soon as possible in order to guarantee accommodations.
Parking
Daily parking is available at the 321 E. Erie Self-Park Garage (Parking C) at the corner of Erie St. & Fairbanks Ct. You may also want to try spothero.com or parkchirp.com to find discount parking near the conference.
Special Thanks
The symposium is made possible, in part, by the generous endowed gift of Harry Staffileno, Jr., DDS, MS to support oncology-related oral health at Northwestern Medicine.
Additional Information
REFUND/CANCELLATION POLICY
If you cancel your participation in this conference, your registration fee less a $50 administrative fee, will be refunded when written notification is received by October 14, 2022. No refunds will be made after that date, however, you may transfer your registration to a colleague.
TARGET AUDIENCE
The target audience for this activity includes medical oncologists, radiation oncologists, surgical oncologists, fellows in training, oncology nurses, oral surgeons, dentists, speech pathologists and allied health professionals treating or interested in treating those with head and neck cancer.
ACCREDITATION STATEMENT
The Northwestern University Feinberg School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CREDIT DESIGNATION
The Northwestern University Feinberg School of Medicine designates this live activity for a maximum of 13.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
OTHER CREDITS
The American Academy of Nurse Practitioners and the American Nurses Credentialing Center accept AMA PRA Category 1 Credit(s)™ from organizations accredited by the ACCME.
LEARNING OBJECTIVES
- Apply a multidisciplinary approach to the treatment of head and neck cancers
- Assess state-of-the art therapeutic options for the treatment of head and neck cancer, including:
- Minimally invasive surgical treatment, including robotic surgery and sentinel lymph node mapping
- Benefits and limitations of proton therapy in the treatment of head and neck cancer
- Incorporation of immunotherapy for treatment of advanced head and neck cancer
- Virtual surgical planning for reconstruction of surgical defects
- Discuss future directions in treatment of head and neck cancer based on the latest basic science and clinical developments, including:
- De-escalation of therapy in the management of oropharyngeal cancer
- Application of circulating tumor DNA as a biomarker for HPV-associated oropharynx cancer
- Molecular assessment of surgical margin
- Risk-stratification of head and neck cancer
- Advances in treatment of nasopharyngeal cancer
- Apply current treatment guidelines to patients with head and neck cancers
For additional information about the event, please contact us at cancer@northwestern.edu
See also the Head and Neck Multidisciplinary Clinic at Northwestern Memorial Hospital webpage.